Abstract Cellular senescence is a stable proliferation arrest associated with an altered secretory pathway, the senescence-associated secretory phenotype. However, cellular senescence is initiated by diverse molecular triggers, such as activated oncogenes and shortened telomeres, and is associated with varied and complex physiological endpoints, such as tumor suppression and tissue aging. The extent to which distinct triggers activate divergent modes of senescence that might be associated with different physiological endpoints is largely unknown. To begin to address this, we performed gene expression profiling to compare the senescence programs associated with two different modes of senescence, oncogene-induced senescence (OIS) and replicative senescence (RS [in part caused by shortened telomeres]). While both OIS and RS are associated with many common changes in gene expression compared to control proliferating cells, they also exhibit substantial differences. These results are discussed in light of potential physiological consequences, tumor suppression and aging.
Introduction
Cell senescence is a state of stable proliferation arrest that normal cells can undergo in response to excessive rounds of cell division (Hayflick and Moorhead 1961) and other diverse stimuli (Adams 2009; Kuilman et al. 2010) . In this manner, senescence restricts the proliferative capacity of impaired or damaged cells, as well as normal cells. Several well-characterized triggers of senescence have been identified including short telomeres (linked to excess rounds of cell division (replicative senescence (RS); Hayflick and Moorhead 1961; Bodnar et al. 1998) , activated oncogenes (oncogene-induced senescence (OIS); Serrano et al. 1997) , and genotoxic and oxidative stress (Saretzki and von Zglinicki 2002; d'Adda di Fagagna 2008) . Upon exposure to these triggers, cells engage a coordinated network of effector pathways. The p53 and pRB pathways are the master regulators of senescence and interact extensively with additional effector processes including DNA damage signalling, regulated autophagy, and profound changes to chromatin structure (d'Adda di Fagagna 2008; Narita et al. 2003; Young et al. 2009 ). Ultimately, these effectors converge on two key phenotypes of senescence, a stable proliferation arrest and an altered secretory pathway, the senescenceassociated secretory phenotype (SASP; Krtolica et al. 2001; Coppe et al. 2008; Kuilman et al. 2008; Acosta et al. 2008) .
Functionally, both RS and OIS serve as potent tumor suppression mechanisms (Michaloglou et al. 2005; Braig et al. 2005; Collado et al. 2005; Chen et al. 2005; Cosme-Blanco et al. 2007; Feldser and Greider 2007) . Both proliferation arrest and SASP are thought to act in concert to mediate tumor suppression. The proliferation arrest restrains tumor growth, and the SASP recruits innate immune cells to clear the damaged premalignant cells (Xue et al. 2007; Kang et al. 2011) . In addition, cell senescence contributes to proper wound healing (Jun and Lau 2010; Krizhanovsky et al. 2008 ). However, senescence has also been implicated in the promotion of aging (Baker et al. 2011; Krtolica et al. 2001) .
In sum, senescence is a complex process activated by diverse triggers in association with varied physiological end points. Conceivably, distinct triggers activate different modes of cell senescence. To investigate this, we performed gene expression profiling to compare two different modes of senescence, OIS and RS, in the same cell type and under, otherwise, identical conditions.
Materials and methods
Cell culture IMR90 primary human diploid fibroblasts were obtained from the Coriell Institute (Camden, NJ, USA). The cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 20 % fetal bovine serum, 2 mM L-glutamine, 25 U/ml penicillin, and 25 μg/ml streptomycin. Cells were maintained in a 37°C, 5 % CO 2 , 3 % O 2 humidified incubator. IMR90 cells were subjected to serial passage approximately every 2 to 3 days.
Cumulative population doublings were calculated using the following equation: ([log(number of cells counted) − log(number of cells plated)]/log(2)). The cells were assayed routinely for markers of senescence (e.g., SA β-gal activity, decreased BrdU incorporation, p16INK4a induction, SAHF formation). Cells were considered replicative senescent when no proliferation was observed for a 2-week period following the final passage and the cells displayed the senescence hallmarks listed above. In the case of the RS model, cells were compared at PD28 (proliferating) and PD90 (RS).
Phoenix-Ampho embryonic kidney cells (SD-3443) were obtained from the American Type Culture Collection (Manassas, VA, USA). The cells were cultured in DMEM supplemented with 10 % fetal bovine serum, 2 mM L-glutamine, 25 U/ml penicillin, and 25 μg/ml streptomycin. Cells were maintained in a 37°C, 5 % CO 2 humidified incubator.
Expression vectors
pBABE-puro and pBABE-puro-H-RAS-V12 (H-RASG12V) retroviral expression vectors were obtained as gifts from Robert Weinberg (Massachusetts Institute of Technology).
Retroviral production and infection
Control and OIS cells were produced by retroviral infection of IMR90 cells with either pBABE-puro or pBABE-puro-H-RAS-V12. Briefly, Phoenix-Ampho cells were transfected with either pBABE-puro or pBABE-puro-H-RAS-V12 plasmids using the calcium phosphate transfection method. Forty-eight hours after transfection, viral supernatants were collected from the Phoenix cells, passed through a 0.45-μm-syringe filter, and applied to IMR90 cells that were pre-treated for 2 h with 8 μg/ml polybrene. The IMR90 cells were incubated for 24 h to facilitate infection. Typically, two sequential rounds of infection were performed. Following the second 24-h incubation, the viral supernatants were removed from the IMR90 cells and replaced with growth medium containing 1 μg/ml puromycin in order to select for positively infected cells. In the OIS model, infections were performed at PD <30.
Senescence-associated β-galactosidase assay Cells were rinsed once with PBS, covered with freshly prepared fixative solution (1X PBS+2 % formaldehyde, 0.2 % glutaraldehyde), and subjected to fixation for 5 min at room temperature. The cells were washed twice with PBS, covered with freshly prepared staining solution (40 mM Na 2 HPO 4 pH 6, 150 mM NaCl, 2 mM MgCl 2 , 5 mM K 3 Fe(CN) 6 , 5 mM K 4 Fe(CN) 6 , 1 mg/ml X-gal (in DMSO)), and incubated 12-16 h at 37°C in a non-CO 2 incubator. The cells were then washed twice with PBS, washed twice with dH 2 O, subjected to drying at room temperature, and imaged using bright field microscopy.
Cell lysis
The dishes (100 mm) of cells were washed once with PBS, aspirated, and scraped into 300-500 μl of hot 1X sample buffer (62.5 mM Tris-HCl pH 6.8, 2 % SDS, 10 % glycerol, 0.1 M DTT, 0.01 % bromophenol blue). The whole cell lysates were collected in microcentrifuge tubes, boiled for 4 min, and homogenized by vigorous vortexing. Lysates were subjected to centrifugation for 5 min at 12,000xg, transferred to fresh microcentrifuge tubes, snap frozen in dry ice/ethanol, and stored at −80°C. The lysates were quantified using the Bradford assay.
Immunoblotting
Whole cell protein lysates were fractionated by SDS-PAGE, immobilized to PVDF membranes, and subjected to immunoblotting utilizing standard methods. The RAS (610001) and p16INK4a (51-1325GR) antibodies were purchased from BD Biosciences. Lamin A/C (2032) and GAPDH (2118) antibodies were purchased from Cell Signaling Technology. Lamin B1 (ab16048) and p21WAF1 (ab7960) antibodies were purchased from Abcam. The cyclin A (H-432) antibody was purchased from Santa Cruz Biotechnology.
RNA isolation and analysis
Total RNA was isolated using the RNeasy Mini Kit (Qiagen, 74104) according to the manufacturer's instructions and included the optional DNase I digestion step. Purified RNA samples were quantified using the NanoVue Plus spectrophotometer (GE Healthcare), assessed for quality using the RNA 6000 Nano Kit and 2100 Bioanalyzer (Agilent), and stored at −80°C.
Microarrays and gene expression analysis
Starting with 50 ng total RNA for each sample, doublestranded cDNA was synthesized using the Ovation Pico WTA System (NuGEN Technologies, #3300), purified with Agencourt RNAClean beads (Beckman Coulter), and subjected to SPIA amplification to produce singlestranded cDNA. The cDNA was again purified, SPIAamplified, subjected to fragmentation, and biotin labeled using the Encore Biotin Module kit (NuGEN Technologies, #4200). The fragmented, biotinylated cDNA was then hybridized to Affymetrix GeneChip Human Genome U133 Plus 2.0 arrays, then stained and scanned with the Affymetrix GeneChip Scanner 3000.
The microarray data were analyzed using the Bioconductor software package. Each array was subjected to background correction and normalization by the GC Robust Multi-array Average (GCRMA) method. Pairwise comparisons were made between the proliferating and RS arrays and also between the control and OIS arrays. Average expression was calculated as the geometric mean of the absolute expression level (equivalent to the unlogged mean of the log-normalized expression values produced by the GCRMA method). T tests were performed on the log-scale expression values to determine statistical significance, and the genes were considered differentially expressed if the fold difference of expression between the senescent and proliferating arrays was greater than 1.5-fold (or less than −1.5-fold) with a BH-FDR-adjusted p value lower than 0.05.
Results
We set out to compare RS and OIS by gene expression profiling. To this end, RS IMR90 fibroblasts were generated by passaging the cells in culture until they entered a stable proliferation arrest (Supplementary Figure 1a) . As well as being proliferation arrested, these cells were judged senescent, compared to control proliferating cells, by a large flat vacuolated morphology, expression of senescence-associated β-galactosidase (SA β-gal; Dimri et al. 1995 ; Supplementary Figure 1b) , downregulation of lamin B1 (Freund et al. 2012; Shimi et al. 2011 ), downregulation of cell cycle gene cyclin A (Riabowol 1992) , and upregulation of cell cycle arrest genes, p21 and p16 ( Fig. 1c ; Noda et al. 1994; Hara et al. 1996) . OIS IMR90 fibroblasts were generated by infecting proliferating primary human fibroblasts with a retrovirus encoding an activated H-RASG12V oncogene. Unlike control-infected cells, these cells also ceased proliferation (data not shown). Similar to RS cells, these cells expressed SA β-gal ( Supplementary Figure 1d) , downregulated lamin B1 and showed gene expression changes indicative of proliferation arrest, including downregulation of cyclin A and upregulation PCNA  NASP  DDX12  DNMT1  CDC25C  MAD2L1  AURKB  CHEK1  MAPK13  MCM4  DHFR  CCNB1  CENPF  TYMS  CKS2  PLK1  CDC20  MCM5  PKMYT1  TOP2A  DDX11  E2F3   0  1   Value   Color Key   RFC1  ORC1L  CDC6  CCNE1  FEN1  MCM4  TIMP1  MAPK13  CTPS  E2F3  MYB  DNMT1  DDX12  MAD2L1  DDX11  UNG  MCM3  NASP  TOP2A  PKMYT1  CCNF  EXOSC9  CDC7  PLK1  CDC25C  CHEK1  PRIM1  DHFR  RRM2  BIRC5  PTTG1  CENPE  MKI67  TYMS  CENPF  MCM6  CDC20  BUB1  AURKB  MCM5  PCNA  CCNA2  CCNB1  RRM1 Fig. 2 Global comparison of RS and OIS gene expression changes. Differentially expressed genes from the RS and OIS Affymetrix Human Genome U133 Plus 2.0 microarray datasets were compared in order to identify common changes. Genes exhibiting a fold change >1.5 (or <-1.5) and BH-FDR-adjusted p value <0.05 were considered differentially expressed. For genes containing multiple Affymetrix probes, the genes were only considered differentially expressed and were included if all the probes changed in the same direction. a Venn diagram of genes that change significantly in RS and OIS. b Venn diagram of genes upregulated in RS and OIS. c Venn diagram of genes downregulated in RS and OIS. d Dot plot of log fold change in OIS versus RS showing all significant changing probes (fold change <1.5 and BH-FDR-adjusted p value <0.05). Symbols indicate probesets that change significantly in RS, OIS, or both, as indicated showing relative expression of proliferation genes in RS. Proliferation genes were taken from Whitfield et al. (2006) . b Heat map showing relative expression of proliferation genes in OIS. c Venn diagram of proliferation genes downregulated in RS and OIS. All the genes included exhibited differential expression (fold change <-1.5 and BH-FDR-adjusted p value <0.05) (Hayflick and Moorhead 1961; Serrano et al. 1997) , we examined expression of a previously collated set of 45 genes whose expression is tightly linked to cell proliferation (Whitfield et al. 2006 ). This list includes many proliferation-promoting genes involved in DNA synthesis and mitosis. As expected, RS cells exhibited marked downregulation of virtually all these proliferation genes (40/45 genes showed fold change >1.5-fold and BH-FDR-adjusted p value <0.05; Fig. 1a, c and Supplementary Datasets). OIS cells downregulated slightly less than half of these genes (19/45), but included key cell cycle genes, such as cyclin B1, cyclin A2, and PCNA (Fig. 1b, c and Supplementary Datasets). Thus, expression changes in both RS and OIS are broadly in accordance with senescence-associated proliferation arrest, validating the expression data sets for other comparisons of OIS and RS.
Taking a long range view of the data, 5,424 differentially expressed genes were identified in the RS cells when compared to control proliferating cells ( Fig. 2a and Supplementary Datasets). Of the 5,424 genes, 2,711 genes were significantly upregulated in the RS cells, while 2,736 genes were significantly downregulated (Fig. 2b, c) . By the same criteria, 3,188 genes were identified as being differentially expressed in the H-RASG12V-induced OIS cells when compared to control-infected proliferating cells ( Fig. 2a and Supplementary Datasets) . Of the 3,188 genes, 1,502 genes were significantly upregulated in the H-RASG12V cells, while 1,687 genes were significantly downregulated (Fig. 2b, c) . Of those genes altered in RS, 32.6 % was also altered in OIS. Of those genes altered in OIS, 55.5 % was also altered in RS (Fig. 2a) . Observations were similar comparing genes according to the direction of change (i.e., upregulated or To obtain a more holistic view of the data, we plotted log fold change in OIS versus log fold change in RS (Fig. 2d ) for all genes that significantly changed their expression in either OIS, RS or both. This analysis confirmed that the RS and OIS programs are qualitatively distinct, involving nonoverlapping upregulated and downregulated genes in each case. In other words, the gene expression changes in OIS were not simply a subset of those in RS, or vice versa. In sum, while there was considerable overlap of gene expression changes between OIS and RS, there were also substantial differences. We used gene set enrichment analysis (GSEA) to compare the gene ontologies of expression changes associated with OIS and RS (Mootha et al. 2003; Subramanian et al. 2005) . While GSEA confirmed the downregulation of proliferation genes in both RS and OIS (not shown), gene ontology sets most enriched in RS included "Extracellular structure organization & biogenesis," "Synapse organization & biogenesis," "Female pregnancy," "Synaptogenesis," and "Hematopoietin interferon class D2000 cytokine receptor activity"; none of these scored highly in OIS (Tables 1 and 2 and Supplementary Datasets; Fig. 3 ). Conversely, gene ontology sets most enriched in OIS included "Myeloid cell differentiation," "Zinc ion binding," "Transition metal ion binding," "Metalloendopeptidase activity," and "Regulation of translational initiation"; none of these sets scored highly in RS (Tables 1 and  2 and Supplementary Datasets).
We also used GSEA to compare genes regulated in OIS and RS according to their positional distribution in chromosome cytogenetic bands. In fact, GSEA failed to obtain strong evidence for chromosomal clusters of co- (Tables 3, 4 , 5, and 6). Of these, only one, at chromosome 6p22, was co-regulated in both RS and OIS. This cluster included many canonical DNA replication histone genes whose expression is typically repressed in non-proliferating senescent cells. In sum, in two different modes of analysis, GSEA pointed to significant differences in the gene expression programs activated in OIS and RS. Next, we took a more focused approach and compared OIS and RS specifically in terms of a key phenotype of senescence, the SASP. To assess the SASP, we used a collection of signature genes assembled by Campisi and coworkers (Coppe et al. 2010) . As expected, both RS and OIS were associated with upregulation of many SASP genes (Fig. 4a, b and Supplementary Datasets). However, some SASP genes were downregulated in both RS and OIS (Fig. 4a, b) . There was incomplete overlap of SASP genes upregulated in OIS and RS (Fig. 4c) .
To better compare and contrast the SASP in OIS and RS, we performed Ingenuity Pathway Analysis (IPA) on those SASP genes upregulated in OIS and RS. This confirmed the similarities and differences (Fig. 5a, b) . Several pathways were regulated in common between OIS and RS, such as "Hepatic fibrosis/Hepatic Stellate Cell Activation," "Granulocyte adhesion and diapedesis," and "Differential Regulation of Cytokine Production in Macrophages and T Helper Cells by IL-17A and IL-17F." However, other pathways were differentially regulated. For example, "Acute phase response signalling," "IL-6 signaling," and "NFkB signaling" scored highly in RS, but not OIS. Conversely, "TREM1 signaling," "Glucocorticoid receptor signaling," and "Atherosclerosis signaling" scored highly in OIS, but not RS. Taken together, these analyses of the SASP confirm the core similarities of OIS and RS, but also point to some differences.
Previously, we have implicated repression of Wnt signaling in both RS and OIS senescent cells as a trigger for chromatin changes in senescent cells (Ye et al. 2007 ). MMP10  IL1B  CSF2  IL1A  EREG  TNFRSF1B  CCL3/CCL3L1  MMP9  MMP12  AREG  ICAM1  MMP3  MMP1  CXCL3  CSF3  SERPINB2  CCL20  MMP14  FGF2  CXCL2  IL8  TNFRSF10C  FGF7/KGFLP1  IGFBP7  FAS  CXCL12  CCL11  CCL13  CCL7  FGF7  IL15  IGFBP2  IGFBP5  CCL2  IGFBP4  IGFBP6  HGF  IGFBP3   0 Count   ANG  IL6  IL1B  CCL2  MIF  NGF  IL15  CXCL12  TNFRSF1B  IGFBP7  IL8  FGF2  MMP3  FGF7  MMP2  IL6ST  FN1  MMP10  MGC31957  TNFRSF11B  FAS  SERPINB2  SERPINE1  CCL26  CXCL11  TIMP1  MMP12  AREG   FGF7/KGFLP1  CXCL1  TIMP2  IGFBP5  EGF  PIGF  TNFRSF10C To better compare the regulation of Wnt signalling in OIS and RS, we compared regulated expression of a set of 24 genes designated as "direct Wnt target genes." This gene set was originally derived from the "Wnt homepage" (http://www.stanford.edu/group/nusselab/ cgi-bin/wnt/target_genes), but then manually curated to include only those genes shown in the literature to be directly regulated by Wnt effector, β-catenin/TCF4. While both OIS and RS were associated with both upregulated and downregulation of direct Wnt target genes (Fig. 6a, b) , on closer analysis, there were substantial differences in the specific genes regulated and their direction of change (Fig. 6c, d ). In fact, for both upregulated and downregulated genes, only a single gene was regulated in common between OIS and RS: NRCAM was upregulated in both RS and OIS, and FST was downregulated in both RS and OIS. Next, we compared expression changes between OIS and RS of a set of 193 genes encoding regulators of chromatin structure and function. This list was manually curated to include genes known to encode (or likely to encode, based on close sequence homology) histonemodifying enzymes, histone chaperones, chromatinbinding proteins, and ATP-dependent nucleosome remodeling complexes. Analysis of these genes again indicated substantial differences between gene expression programs in OIS and RS. Approximately, 10 genes were upregulated uniquely in either RS or OIS (Fig. 7a-c) . However, only 1 gene, nuclear receptor coactivator 3 (NCOA3), was upregulated in both RS and OIS. Interestingly, many more genes were downregulated in RS than OIS (Fig. 7a, b, d) .
PLAUR
Finally, we compared OIS and RS in terms of a set of genes whose regulation is closely associated with regulation of p16, a key effector of cellular senescence. Specifically, this gene set, "p16-linked genes," includes genes whose expression is upregulated or downregulated in p16-expressing hTERT-immortalized human fibroblasts that spontaneously upregulate p16 and senesce (Jeyapalan and Sedivy 2013) . Many p16-linked genes were downregulated in common between OIS and RS ( Fig. 8a-c) . However, substantially more of the p16-linked genes were upregulated in RS than in OIS (Fig. 8a, b, d ).
Discussion
As expected, this comparative analysis reveals broad similarities between OIS and RS. First, both OIS and RS are associated with repression of many proliferationpromoting genes. In both cases, this is known to contribute to stable senescence-associated proliferation arrest. Second, both OIS and RS are associated with activation of many genes that constitute the SASP.
However, beyond these broad and alreadydocumented similarities, our analysis also points to substantial differences between the gene expression programs underlying RS and OIS. In terms of the overall gene expression programs activated by OIS and RS, there are more differences than similarities in regulated genes. This is reflected in the largely different outputs of the GSEA analyses from OIS and RS. Moreover, in all of the specific pathways and gene sets examined-SASP, Wnt target genes, and chromatin regulatorsthere are core overlaps but also substantial differences between OIS and RS. Importantly, the differences in OIS and RS do not appear to be due to either program being a deficient or impaired senescence program; the differences between OIS and RS are qualitative, not just quantitative.
While OIS and RS are often considered to be similar (Suram et al. 2012) , differences between these models are not surprising, given their very different triggers. In the model examined here, the OIS model is triggered by expression of an activated Ras oncogene. This is expected to activate many signalling, effector and gene expression programs that are absent from RS cells. Although this in vitro model depends on ectopic expression of activated Ras, this and similar models are thought to recapitulate the OIS program activated in vivo (Michaloglou et al. 2005; Braig et al. 2005; Collado et al. 2005; Chen et al. 2005) . Even though OIS is ultimately thought to be associated with downregulation of oncogene signalling (Courtois-Cox et al. 2006) , the substantial differences between proliferating and OIS cells indicate sustained differences in cell effector programs.
One key effector of different modes of cell senescence is the p16-pRB pathway (Adams 2009; Kuilman et al. 2010) . Interestingly, our analysis shows that a set of genes whose upregulation coincides with upregulation of p16 in one model of senescence (Jeyapalan and Sedivy 2013) are quite differently regulated between OIS and RS in our study. This is consistent with the idea that even the p16-pRB effector pathway is networked differently between OIS and RS.
As well as reflecting different triggers and effector pathways, differences between OIS and RS might also reflect differences in in vivo function and/or pathology between OIS and RS. Both RS and OIS are thought to act as tumor suppression mechanisms (Braig et al. 2005; Michaloglou et al. 2005; Chen et al. 2005; Bartkova et al. 2006; Feldser and Greider 2007; Cosme-Blanco et al. 2007; Collado et al. 2005) . OIS mediates tumor suppression in direct response to a potentially cancer- CBX3  HMGB1  RAD21  ACTL6A  TTF2  PCM1  SMC5  RBBP4  EID3  ASF1B  RAD54L  SMAP2  CHRAC1  RBBP7  SMC1A  RAD54B  CHAF1B  SMC4  DNMT1  SSRP1  EZH2  SMC6  SMC2  SMC3  HAT1  BAZ1B  CHD1L  CTCFL  SUV39H2  POLE3  SIRT1  DNMT3A  TRDMT1  ATAD2  HMGB2  CBX5  HMGN2  HELLS  SMARCC1  SETDB1  HDAC2  SMARCAD1  SETD2  DNMT3B  ZMYND8  SUV420H1  BRD7  BPTF  AFF3 /// MLL  MBD5  GTF3C4  BAZ1A  MYST3  RNF2  ZBTB38  ELP3  TRIM24  PCGF6  NSD1  SMARCA4  PHC1 /// PHC1B  HMGA2  CHD1  HDAC1  CHD4  SUV39H1  PRDM2  DOT1L  ARID1A  PBRM1  MTA2  PRMT1  EED  HMGB3  CBX2  CHAF1A  SMARCB1  MED1  TRIM28  NAP1L4  SRCAP  HDAC11  BRWD1  CBX4  CBX7  EZH1  CBX6  ZBTB4  ERCC6  NCOA3  ATRX NCAPH  HIST1H4L  BIRC5  BAIAP2L1  KIF23  BUB1B  MFAP5  CENPK  HMGB2  DLGAP5  ANLN  HIST1H2BH  GAS2L3  CKAP2  NCAPG  LMNB1  SHCBP1  BUB1  HELLS  CCNB1  PTGS1  KIF4A  CASC5  RDH10  KIAA0101  FBXO5  UBE2T  HJURP  RAD51AP1  CDC20  NEK2  GPR155  HIST1H1E  LMOD1  RBL1  UBE2C  PPP1R14A  GOLGA9P  HIST1H4C  HIST1H4K  DMD  KIAA1524  PLK4  PPP1R3C  MEST  CPA4  NUF2  CCNA2  ASPM  MKI67  TACC3  KIF2C  HIST1H3B  GPSM2  FANCD2  CDCA2  CDKN3  IGFBP3  FOXM1  SPAG5  PHGDH  CD200  DEPDC1B  CDCA8  HIST1H4B  KIF20A  NDC80  TOP2A  HIST1H2AE  NUSAP1  NCAPG2  CENPF  CEP55  CCNB2  IQGAP3  CRYAB  TYMS  CYP2U1  SERPINE2  PAMR1  KIF11  PRC1  PTTG1  CENPE  SFRP1  TPX2  SERPING1  IGFBP6  SAT1  STC1  MMP1  C15orf48  ENC1  ICAM1  HIST1H2BG  CDKN2A causing genetic alteration (Serrano et al. 1997 ). In contrast, RS mediates tumor suppression in response to a finite number of normal cell divisions (Hayflick and Moorhead 1961) . While cell division is clearly necessary for tumor growth, cell division per se is not typically regarded as oncogenic in the same way as an activated oncogene. Thus, OIS might reflect a more active and definitive tumor suppression mechanism than RS. Accordingly, it is conceivable that some immune regulatory pathways preferentially regulated in OIS compared to RS (TREM1 signalling and Glucocorticoid Receptor signalling by IPA analysis, and myeloid cell differentiation by GSEA) reflect this more urgent tumor suppressor function of OIS. Conversely, RS, as perhaps representative of telomere shortening and more generic cell stress (Hayflick and Moorhead 1961; Bodnar et al. 1998; Sherr and DePinho 2000) , might be more informative regarding gene expression changes in aged tissues. Of note, both "IL-6 signaling" and "NF-κB signaling" pathways scored highly in RS, but not OIS. IL-6 is a key component of age-associated inflammation, so-called "inflammaging," a candidate driver of the aging process (Singh and Newman 2011) . Recent studies have also implicated elevated NF-κb activity as a driver of aging (Osorio et al. 2012) . Thus, our analyses are consistent with the idea that age-associated accumulation of RS cells, perhaps caused by age-associated telomere shortening (Blasco 2005) , might be a significant contributor to these pro-aging pathways. Other notable differences between OIS and RS are more difficult to rationalize based on our current understanding of senescence. Of particular note, high ranking of the "Synaptogenesis" set in RS, but not OIS, is largely driven by upregulation of protocadherin B genes, a 16-gene cluster on chromosome 5, in RS, but not OIS (Fig. 3 and Supplementary Datasets). The function of these genes is unknown, but they are thought to be involved in the establishment and function of specific cell-cell connections (Chen and Maniatis 2013) . This might reflect a level of cell-cell interaction specific to RS over OIS. Deeper functional analysis of these genes in senescence might lead to substantial novel functional insights.
Just as distinct triggers (activated oncogene or replicative exhaustion) induce different modes of senescence in the same cell type (IMR90 fibroblasts), so senescent phenotypes are likely to be divergent between cell types, in ways that could impact tissue specific functions and pathologies. For example, senescent human corneal keratocytes do not express SASP, but instead, decrease the expression of IL-6, and this might impact their function ). Very interestingly, while senescent vascular smooth muscle cells appear to express a SASP, they also exhibit a marked pro-calcificatory phenotype that might promote the atherosclerosis (Burton et al. 2009 ).
To summarize, here we have presented data based on expression profiling of primary human fibroblasts that supports the emerging notion that senescence is perhaps not a single unique and unambiguous cell state (Salama et al. 2014) ; rather, senescence, like "differentiation," might be a collection of related but different cell states with some features in common, such as stable proliferation arrest and a secretory phenotype that is frequently pro-inflammatory. Just as there is no single definition of a differentiated cell, so there might be no single definition of a senescent cell. showing relative expression of p16-linked genes in RS. The list of p16-linked genes was based on genes whose expression is either upregulated or downregulated in p16-expressing hTERT-immortalized human fibroblasts that spontaneously upregulate p16 (Jeyapalan and Sedivy 2013) . Genes exhibiting a fold change >1.5 (or <-1.5) and BH-FDR-adjusted p value <0.05 were considered differentially expressed. b Heat map showing relative expression of chromatin regulatory genes in OIS. c Venn diagram of downregulated p16-linked genes in RS and OIS. d Venn diagram of upregulated p16-linked genes in RS and OIS
